With over 25 years of specialized experience in dermatology and rheumatology, Indero, formerly known as Innovaderm, is a leading full-service Contract Research Organization (CRO) and a trusted partner in clinical development.
We provide full operational support across all phases of clinical trials, leveraging scientific rigor, therapeutic expertise, and innovative methodologies to drive high-quality outcomes and advance patient care.
The Only Dermatology and Rheumatology Dual Focus CRO In Europe
Our European presence is anchored by 3 key operational hubs in Poland, Germany, and Spain, enabling seamless trial execution and regulatory navigation across the continent. We extend our reach to all European countries, ensuring local expertise, cultural alignment, and operational agility wherever you need us.
Duong Nguyen
Head of Clinical Operations at Inmagene Biopharmaceuticals.
âWorking with Indero for our alopecia areata trial has been a smooth and exceptional experience, marked by their extensive expertise, proactive approach, and seamless collaboration.â
Innovadermâs profound understanding of alopecia areata and their forward-thinking strategy sets them apart. The team’s detailed explanations, thorough research, and well-considered solutions are commendable, especially in risk mitigation. Our collaboration with Innovaderm has been smooth and cooperative, free from finger-pointing or difficult interactions. Both teams have meshed well, working together towards the best outcomes for the study and the patients. It has been a pleasure, and we look forward to many more successful studies together. We highly recommend Innovaderm for their professionalism and expertise.
Our organic growth is a testament to our commitment to building a robust and independent presence across the continent, achieved without acquisitions.
15
AVERAGE YEARS OF INDUSTRY EXPERIENCE
HANDPICKED EXCELLENCEâ
Our team members are meticulously selected to ensure they embody our high standards and core values, fostering a culture of excellence and integrity.â
260+
TRUSTED EUROPEAN DERMATOLOGY KEY OPINION LEADERS (KOLs)
LOCAL EXPERTISE, GLOBAL IMPACTâ
Our European team leverages local expertise to drive innovation and success, making a significant impact on our global footprint.â
3,100
SITES
INVESTIGATORS IN OUR DATABASE (& GROWING)
Strategic site selection for dermatology & rheumatology clinical trials, based on relevant experience in your indication, positive indicators in efficacy assessments, and proven recruitment track records.
Our European Team
Our European team is not simply an extension of our North American operations. It is a dedicated group of Indero professionals who bring deep, localized expertise and a nuanced understanding of the European market.
Thanks to our strong organic foundation, we have grown, and continue to expand, by hiring individuals who share our values, embrace a growth mindset, and bring specialized experience in dermatology and rheumatology.
Our EU and NA teams operate in seamless synergy, fostering collaboration, avoiding silos, and ensuring a cohesive, strategic approach to every project.
As your dermatology CRO, Indero provides expertise across a range of dermatological indications. Our team comprehends the intricacies of skin-related conditions, applying depth and precision to each study we support, including:
As your rheumatology CRO, Indero offers the expertise to advance a broad spectrum of indications. Our team understands the complexities and unique demands of immune-mediated diseases, bringing depth and precision to every study we support, including:
Rheumatoid Arthritis (RA)
Osteoarthritis (OA)
Scleroderma/systemic sclerosis (SSc)
Psoriatic Arthritis (PsA) and Juvenile PsA
Systemic Lupus Erythematosus (SLE) and Juvenile SLE
Lupus Nephritis
Osteoporosis
Idiopathic Inflammatory Myopathies (IIM), including Dermatomyositis (DM), polymyositis (PM), and juvenile inflammatory myopathies (JIIMs)
My joint effort with Innovaderm has been instrumental in advancing medical research.
Their expertise in clinical trials has greatlyâ complemented our healthcare initiatives.â I look forward to continuing this successful partnership.â Warsaw, Poland
Prof. Irena Walecka- Herniczekâ
Central Clinic Hospital, Warsawâ
Innovadermâs performance of this global phase 1b study was very impressive.
Innovadermâs performance of this global phase 1B study was very impressive: diligent coordination and supervision and trial conduct at the highest level. We truly value our nice collaboration and the open and professional communication on all study parts. Netherlands
Prof. Robert Rissmannâ
Professor Translational Dermatology
Research Director
Collaborating with Innovaderm in clinical trials has been an outstanding experience.â
Collaborating with Innovaderm in clinical trials has been an outstanding experience. Their team is well organized, ensuring smooth study execution from start to finish. What sets Innovaderm apart is their deep understanding of dermatology and their dedication to both investigators and patients. As a physician, being part of groundbreaking research that significantly impacts my patientsâ quality of life, has been incredibly fulfilling. Madrid, Spain
Dr. Ălvaro GonzĂĄlez Cantero - Scientific Director
Indero boasts a team of over 65+ and growing skilled professionals across Czech Republic, France, Germany, Hungary, Netherlands, Poland, Serbia, Spain, and the United Kingdom.
Juan Ovalles
Senior Director, Rheumatology
Pedro Diaz de Rada
Senior Director, Project Management
Beatriz Aguirre
Senior Director, Project Management
Dorota Pieczynska
Manager, Site Selection and Contracting, Europe Project Management
Inderoâs Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8â12 weeks to â€3 days, and lowers costs, helping teams make informed go/no-go decisions faster.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
